| Lastest Insider Transactions Of Dianthus Therapeutics, Inc. /DE/ ( DNTH ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Garcia Marino | CEO AND PRESIDENT | 2026-03-12 | Sell | 122,918 | 81.49 | 10,016,381 | 2026-03-13 20:30:07 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Garcia Marino | CEO AND PRESIDENT | 2026-03-12 | Option Exercise | 122,918 | 6.70 | 823,551 | 2026-03-13 20:30:07 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 2026-03-12 | Sell | 43,682 | 81.49 | 3,559,495 | 2026-03-13 20:30:05 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | CARR EDWARD | CHIEF ACCOUNTING OFFICER | 2026-03-12 | Option Exercise | 43,682 | 20.45 | 893,259 | 2026-03-13 20:30:05 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat | EVP, Head of R&D | 2026-03-12 | Sell | 33,830 | 81.48 | 2,756,469 | 2026-03-13 20:30:03 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat | EVP, Head of R&D | 2026-03-12 | Option Exercise | 33,830 | 18.15 | 614,166 | 2026-03-13 20:30:03 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO & CBO | 2025-12-04 | Sell | 20,000 | 45.18 | 903,600 | 2025-12-05 20:00:04 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO & CBO | 2025-12-04 | Option Exercise | 20,000 | 8.44 | 168,800 | 2025-12-05 20:00:04 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat | EVP, Head of R&D | 2025-11-13 | Sell | 196,538 | 37.55 | 7,379,888 | 2025-11-14 21:00:06 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat | EVP, Head of R&D | 2025-11-13 | Option Exercise | 196,538 | 15.25 | 2,998,136 | 2025-11-14 21:00:06 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO & CBO | 2025-09-09 | Sell | 20,000 | 35.00 | 700,000 | 2025-09-11 17:20:43 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO & CBO | 2025-09-09 | Sell | 20,000 | 35.00 | 700,000 | 2025-09-11 17:20:43 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO & CBO | 2025-09-09 | Sell | 20,000 | 35.00 | 700,000 | 2025-09-11 17:20:43 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO & CBO | 2025-09-09 | Option Exercise | 20,000 | 8.44 | 168,800 | 2025-09-11 17:20:43 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO & CBO | 2025-09-09 | Option Exercise | 20,000 | 8.44 | 168,800 | 2025-09-11 17:20:43 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO & CBO | 2025-09-09 | Option Exercise | 20,000 | 8.44 | 168,800 | 2025-09-11 17:20:43 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO & CBO | 2025-09-09 | Sell | 20,000 | 35.00 | 700,000 | 2025-09-11 17:20:43 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO & CBO | 2025-09-09 | Option Exercise | 20,000 | 8.44 | 168,800 | 2025-09-11 17:20:43 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO & CBO | 2025-09-09 | Sell | 20,000 | 35.00 | 700,000 | 2025-09-11 17:20:43 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Savitz Ryan | CFO & CBO | 2025-09-09 | Option Exercise | 20,000 | 8.44 | 168,800 | 2025-09-11 17:20:43 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Fairmount Funds Management LLC | Directior 10% Owner | 2023-09-29 | Buy | 24,670 | 13.63 | 336,252 | 2023-10-03 16:00:40 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Fairmount Funds Management LLC | Directior 10% Owner | 2023-09-26 | Buy | 30,000 | 13.15 | 394,500 | 2023-09-28 17:09:20 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Randhawa Simrat | Chief Medical Officer | 2023-09-21 | Buy | 4,000 | 13.20 | 52,800 | 2023-09-25 16:15:07 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Fairmount Funds Management LLC | Directior 10% Owner | 2023-09-19 | Buy | 30,000 | 13.20 | 396,000 | 2023-09-21 16:23:57 |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | Fairmount Funds Management LLC | Directior 10% Owner | 2023-09-11 | Buy | 24,254 | 11.20 | 271,680 | 2023-09-13 21:17:54 |
